Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROOF: NBHO in Ischemic Stroke
NCT03500939Phase 2Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2019
- Primary completion
- May 2022
- Modality
- Inhalation Devices
- Countries
- 5
01
Overview
A Phase 2 trial of oxygen in ischemic stroke, sponsored by University Hospital Tübingen. Started Aug 2019; status: terminated.
02
Drugs
oxygen
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03500939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500939.